JP2016505551A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505551A5
JP2016505551A5 JP2015545760A JP2015545760A JP2016505551A5 JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5 JP 2015545760 A JP2015545760 A JP 2015545760A JP 2015545760 A JP2015545760 A JP 2015545760A JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocyclyl
cycloalkyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015545760A
Other languages
English (en)
Japanese (ja)
Other versions
JP6283862B2 (ja
JP2016505551A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/075238 external-priority patent/WO2014086712A1/en
Publication of JP2016505551A publication Critical patent/JP2016505551A/ja
Publication of JP2016505551A5 publication Critical patent/JP2016505551A5/ja
Application granted granted Critical
Publication of JP6283862B2 publication Critical patent/JP6283862B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015545760A 2012-12-07 2013-12-02 新規インダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP6283862B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12196011.6 2012-12-07
EP12196011 2012-12-07
PCT/EP2013/075238 WO2014086712A1 (en) 2012-12-07 2013-12-02 New indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2016505551A JP2016505551A (ja) 2016-02-25
JP2016505551A5 true JP2016505551A5 (enExample) 2017-01-19
JP6283862B2 JP6283862B2 (ja) 2018-02-28

Family

ID=47290800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545760A Expired - Fee Related JP6283862B2 (ja) 2012-12-07 2013-12-02 新規インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (2) US20140163025A1 (enExample)
EP (1) EP2928886B1 (enExample)
JP (1) JP6283862B2 (enExample)
AR (1) AR093864A1 (enExample)
TW (1) TW201439076A (enExample)
UY (1) UY35171A (enExample)
WO (1) WO2014086712A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6283862B2 (ja) 2012-12-07 2018-02-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規インダニルオキシジヒドロベンゾフラニル酢酸
MX2016002974A (es) 2013-09-09 2016-06-02 Peloton Therapeutics Inc Eteres de arilo y sus usos.
AU2014372114A1 (en) 2013-11-14 2016-06-09 Cadila Healthcare Limited Novel heterocyclic compounds
ES2737148T3 (es) 2013-12-16 2020-01-10 Peloton Therapeutics Inc Análogos de sulfona y sulfoximina cíclicos y usos de los mismos
CN104177320B (zh) * 2014-08-27 2016-03-02 广东东阳光药业有限公司 一种脲取代联苯类化合物及其组合物及用途
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
EP3267792A4 (en) 2015-03-11 2018-09-26 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
EP3268362B1 (en) 2015-03-11 2021-10-20 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10807948B2 (en) * 2015-03-11 2020-10-20 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
WO2016168510A1 (en) 2015-04-17 2016-10-20 Peloton Therapeutics, Inc. Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
EA035867B1 (ru) * 2016-04-29 2020-08-24 Байер Фарма Акциенгезельшафт Синтез индазолов
HUE049331T2 (hu) * 2016-04-29 2020-09-28 Bayer Pharma AG Indazolok szintézise
CN110312714B (zh) 2017-01-26 2022-12-09 勃林格殷格翰国际有限公司 苄基氧基吡嗪基环丙烷甲酸、其药物组合物和用途
US10793530B2 (en) 2017-01-26 2020-10-06 Boehringer Ingelheim International Gmbh Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN110177773B (zh) 2017-01-26 2023-08-25 勃林格殷格翰国际有限公司 苄基氨基吡啶基环丙烷羧酸、其药物组合物及其用途
US10913720B2 (en) 2017-01-26 2021-02-09 Boehringer Ingelheim International Gmbh Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
WO2018146008A1 (en) 2017-02-08 2018-08-16 Boehringer Ingelheim International Gmbh Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
CA3056551A1 (en) 2017-03-13 2018-09-20 Impetis Biosciences Limited Fused bicyclic compounds, compositions and applications thereof
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
WO2019204609A1 (en) 2018-04-19 2019-10-24 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
BR112020026746A2 (pt) 2018-07-13 2021-03-30 Gilead Sciences, Inc. Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição.
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
EP1726580A4 (en) * 2004-03-15 2008-02-13 Takeda Pharmaceutical AMINOPHNYLPROPANO ACID DERIVATIVE
WO2007033002A1 (en) * 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
JPWO2007114213A1 (ja) 2006-03-30 2009-08-13 旭化成ファーマ株式会社 置換二環式環状誘導体及びその用途
ES2379661T3 (es) 2006-06-27 2012-04-30 Takeda Pharmaceutical Company Limited Compuestos cíclicos condensados
MX2010014571A (es) * 2008-06-25 2011-03-25 Daiichi Sankyo Co Ltd Compuestos de acido carboxilico.
JP5551707B2 (ja) 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環gpr40調節因子
US20120172351A1 (en) * 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
HUE025363T2 (en) 2010-12-01 2016-02-29 Boehringer Ingelheim Int Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome
BR112015009376A2 (pt) 2012-11-28 2017-07-04 Boehringer Ingelheim Int ácidos indaniloxidihidrobenzofuranilacéticos
JP6283862B2 (ja) 2012-12-07 2018-02-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規インダニルオキシジヒドロベンゾフラニル酢酸

Similar Documents

Publication Publication Date Title
JP2016505551A5 (enExample)
US8541457B2 (en) Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
CA2583259A1 (en) Aromatic ring fused pyrimidine derivative
RU2403258C2 (ru) Тиазолилдигидроиндазолы
JP2015511613A5 (enExample)
RU2011109190A (ru) Бензоксазолы, бензтиазолы и родственные аналоги в качестве модуляторов сиртуина
RU2019123031A (ru) (аза)индол-, бензотиофен- и бензофуран-3-сульфонамиды
TW200617001A (en) Novel glucitol derivative, its prodrug, their salt and diabetic therapeutic agent containing the same
JP2013510825A5 (enExample)
RU2011153772A (ru) Фторированные аминотриазольные производные
WO1998052611A1 (en) Medicinal composition for prevention or treatment of hepatopathy
JP2009263394A5 (enExample)
RU2002131887A (ru) Замещенные в орто-положении амиды антраниловой кислоты и их применение в качестве лекарственных средств
JP2011519863A5 (enExample)
JP2011521911A5 (enExample)
JP2009535307A5 (enExample)
JP2014532626A5 (enExample)
JP2018536648A5 (enExample)
JP2012519691A5 (enExample)
RU2010134411A (ru) Фенилацетамидное производное
JP2018509474A (ja) インダン酢酸誘導体を用いる肝疾患の治療方法
RU2008107733A (ru) Ингибиторы gsk-3
JP2020513415A5 (enExample)
RU2007124686A (ru) Биарилоксиметилареновые карбоновые кислоты
JP2015524483A5 (enExample)